"The mystery of figure 2" - A case for ovulatory migraine? [9]

Headache

Volumn 47, Issue 8, 2007, Pages 1229-1230

  Calhoun, Anne H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; GESTAGEN; NANDROLONE; ORAL CONTRACEPTIVE AGENT; PLACEBO;

DRUG DOSE REGIMEN; HEADACHE; HUMAN; LETTER; MENSTRUAL MIGRAINE; MIGRAINE; ORAL CONTRACEPTION; OVULATION; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

CLINICAL TRIALS AS TOPIC; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; MIGRAINE DISORDERS;

EID: 34648818225     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00901.x     Document Type: Letter

References (1)

1. Sulak P, Willis S, Kuehl T, Coffee A, Clark J. Headaches and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache. 2007 47 : 27 37.